OPEN ANGLE GLAUCOMA (OAG)

This early-stage study is testing a small, dissolving implant placed in the eye to lower internal eye pressure in adults with open-angle glaucoma or ocular hypertension. About 12 participants will receive a single implant and be followed for about a year to see how well it works,…

This is a small, early-stage study testing whether a new eye drop called QLS-111 can improve blood flow and widen blood vessels in the back of the eye. It will involve 14 people with non-proliferative diabetic retinopathy, open-angle glaucoma, or normal tension glaucoma. Particip…

This study compares two different glaucoma surgery techniques performed during cataract surgery. Researchers want to see which method works better at lowering eye pressure and reducing the need for glaucoma medications. The trial will include 100 patients with both cataracts and …

This study is testing a new tiny drainage device called the VisiPlate for people with advanced open-angle glaucoma that hasn't responded well to other treatments. The goal is to see if safely lowering the dangerous fluid pressure inside the eye can help protect vision. About 165 …

This is the first study in people to test the safety of a new gene therapy called ER-100 for two conditions that damage the optic nerve and cause vision loss: open-angle glaucoma and NAION. Researchers will give a single dose to 18 adults and closely monitor them for side effects…

This study is testing an updated tool used by doctors to place a tiny, long-acting implant in the eye for glaucoma. The implant slowly releases medication to help control high eye pressure. Researchers will observe 30 adult patients with open-angle glaucoma to see how well the ne…